Lin Yao

Lin Yao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in Aging Cell
Verified
Journal Article
Open access
ZZZeyu Zhu
Zeyu Zhu
JLJunfeng Lu
Junfeng Lu
SWShuyi Wang
Shuyi Wang
WPWeijia Peng
Weijia Peng
YYYang Yang
Yang Yang
RPRongbiao Pi
Rongbiao Pi
Acrolein, an unsaturated aldehyde, is increased in the brain of Alzheimer's disease (AD) patients and identified as a potential inducer of sporadic AD. Synaptic dysfunction, as a typical pathological change occurring in the early stage of AD, is most closely associated with the severity of dementia. However, there remains a lack of clarity on the mechanisms of acrolein inducing AD‐like pathology and synaptic impairment. In this study, acrolein‐treated primary cultured neurons and mice were applied to investigate the effects of acrolein on cognitive impairment and synaptic dysfunction and their signaling mechanisms. In vitro, ROCK inhibitors, Fasudil, and Y27632, could attenuate the axon ruptures and synaptic impairment caused by acrolein. Meanwhile, RNA‐seq distinct differentially expressed genes in acrolein models and initially linked activated RhoA/Rho‐kinase2 (ROCK2) to acrolein‐induced synaptic dysfunction, which could regulate neuronal cytoskeleton and neurite. The Morris water maze test and in vivo field excitatory postsynaptic potential (fEPSP) were performed to evaluate spatial memory and long‐term potential (LTP), respectively. Acrolein induced cognitive impairment and attenuated LTP. Furthermore, the protein level of Synapsin 1 and postsynaptic density 95 (PSD95) and dendritic spines density were also decreased in acrolein‐exposed mice. These changes were improved by ROCK2 inhibitor Fasudil or in ROCK2+/− mice. Together, our findings suggest that RhoA/ROCK2 signaling pathway plays a critical role in acrolein‐induced synaptic damage and cognitive dysfunction, suggesting inhibition of ROCK2 should benefit to the early AD.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JWJingya Wang
Jingya Wang
LYLin Yao
Lin Yao
XWXiaoli Wu
Xiaoli Wu
QGQi Guo
Qi Guo
SSShengxuan Sun
Shengxuan Sun
YCYongjun Chen
Yongjun Chen
Background. Doxorubicin (DOX) is a commonly used chemotherapeutic drug but is limited in clinical applications by its cardiotoxicity. Neiguan acupoint (PC6) is a well‐recognized acupoint for the treatment of cardiothoracic disease. However, whether acupuncture at PC6 could be effective in preventing DOX‐induced cardiotoxicity is still unknown. Methods. A set of experiments were performed with myocardial cells, wild type, inducible nitric oxide synthase knockout (iNOS‐/‐), and myocardial‐specific ablation arginase 2 (Myh6‐ARG 2‐/‐) mice. We investigated the protective effect and the underlying mechanisms for electroacupuncture (EA) against DOX‐induced cardiotoxicity by echocardiography, immunostaining, biochemical analysis, and molecular biotechnology in vivo and in vitro analysis. Results. We found that DOX‐mediated nitric oxide (NO) production was positively correlated with the iNOS level but has a negative correlation with the arginase 2 (ARG 2) level in both myocardial cells and tissues. Meanwhile, EA at PC6 alleviated cardiac dysfunction and cardiac hypertrophy in DOX‐treated mice. EA at PC6 blocked the upregulation of NO production in accompanied with the downregulated iNOS and upregulated ARG 2 levels in myocardial tissue induced by DOX. Furthermore, knockout iNOS prevented cardiotoxicity and EA treatment did not cause the further improvement of cardiac function in iNOS‐/‐ mice treated by DOX. In contrast, deficiency of myocardial ARG 2 aggravated DOX‐induced cardiotoxicity and reduced EA protective effect. Conclusion. These results suggest that EA treatment at PC6 can prevent DOX‐induced cardiotoxicity through modulating NO production by modulating the iNOS/ARG 2 balance in myocardial cells.

7 July 2025 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
XYXiaoyun Yang
Xiaoyun Yang
JWJiaxin Wang
Jiaxin Wang
JZJiahao Zhang
Jiahao Zhang
MZMengjie Zhang
Mengjie Zhang
AHAnran Hao
Anran Hao
LYLin Yao
Lin Yao
Neurovascular coupling (NVC) is a vital regulatory mechanism that synchronizes neural activity with vascular responses to support brain function. Although the precise mechanisms of NVC remain incompletely elucidated, its dysfunction is increasingly implicated in the pathogenesis of various neurological disorders. This review synthesizes recent advancements in understanding the vascular cascade, emphasizing key dynamic regulators of NVC, including mechanical forces and diffusible signals mediated by blood flow. We explore the intricate bidirectional interactions between the vasculature and neurons, highlighting their interdependent roles in neurovascular regulation. Using major depressive disorder (MDD) as a case study, we further discuss emerging evidence linking vascular dysfunction and impaired NVC to MDD pathophysiology. These insights position NVC as a promising therapeutic target for emotional disorders, underscoring the pivotal roles of hemodynamic signaling in neurovascular regulation.

14 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XZXiaochen Zhang
Xiaochen Zhang
YWYaru Wang
Yaru Wang
SXSong Xue
Song Xue
LGLi Gong
Li Gong
JYJinglan Yan
Jinglan Yan
LYLin Yao
Lin Yao
Depression is a prevalent mental disorder characterized by unknown pathogenesis and challenging treatment. Recent meta-analyses reveal an association between cardiovascular risk factors and an elevated risk of depression. Despite this, the precise role of vascular injury in depression development remains unclear. In this investigation, we assess vascular system function in three established animal models of depression— chronic unpredictable mild stress (CUMS), chronic social defeat stress (CSDS) and maternal separation (MS)—utilizing ultrasonography and laser Doppler measurement. All three model animals exhibit anhedonia and despair-like behavior. However, significant microvascular dysfunction (not macrovascular) is observed in animals subjected to CUMS and CSDS models, while such dysfunction is absent in the MS model. Statistical analysis further indicates that microcirculation dysfunction is not only associated with depression-like behavior but is also intricately involved in the development of depression in the CUMS and CSDS models. Furthermore, our study has proved for the first time that endothelial nitric oxide synthase-deficient (eNOS+/−) mice, which is a classic model of vascular endothelial injury, showed depression-like behavior which occurred two months later than microvascular dysfunction. Notably, the mitigation of microvascular dysfunction successfully reverses depression-like behavior in eNOS+/− mice by enhancing nitric oxide production. In conclusion, this study unveils the pivotal role of microvascular dysfunction in the onset of depression induced by chronic stress in adulthood and proposes that modulating microvascular function may serve as a potential intervention in the treatment of depression.

10 September 2025 in Sleep Medicine
Verified
Journal Article
Closed access
YWYaru Wang
Yaru Wang
XZXiaochen Zhang
Xiaochen Zhang
LJLi-Ming Jin
Li-Ming Jin
XYXiaoyun Yang
Xiaoyun Yang
KHKuizhang Han
Kuizhang Han
LYLin Yao
Lin Yao

10 June 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
CWChaofan Wan
Chaofan Wan
YXYucen Xia
Yucen Xia
JYJinglan Yan
Jinglan Yan
WLWeipeng Lin
Weipeng Lin
YZYuanjia Zheng
Yuanjia Zheng
YCYongjun Chen
Yongjun Chen
Background: Imbalances between excitatory and inhibitory signals have been implicated in the pathophysiology of schizophrenia. Electroacupuncture (EA) is commonly used in clinical practice to address neuropsychiatric conditions. However, the exact therapeutic mechanisms underlying EA's effects on schizophrenia remain poorly understood. Methods: We employed Erbb4‐nNos −/− mice, which model the genetic deficits observed in schizophrenia, as a model system for our study. The locomotor activity, social behavior, sensorimotor gating ability, working memory, spatial learning and memory, and motor skills and coordination of mice were assessed using the open‐field test, three‐chamber social interaction test, prepulse inhibition (PPI) test, Y‐maze, Morris water maze, and rotarod tests. Whole‐cell patch‐clamp recordings were performed to detect excitatory and inhibitory synaptic transmission and the intrinsic excitability of pyramidal neurons. Results: EA alleviated behavioral deficits associated with schizophrenia in these mice. Notably, EA also enhanced GABAergic transmission and decreased the excitability of pyramidal neurons. Simultaneously, the selective nNOS inhibitor L‐NPA blocked the therapeutic effects of EA on behavioral deficits and synaptic transmission. Conclusions: EA improved schizophrenia‐like behavioral impairments and restored the balance between excitatory and inhibitory signaling, possibly through the upregulation of presynaptic GABA release. Furthermore, nitric oxide (NO) signaling may play a critical role in the observed benefits. These findings underscore the significance of excitatory–inhibitory (E/I) balance in mediating the therapeutic effects of EA, highlighting its potential as an intervention strategy for schizophrenia.